Innovating Cancer Care Through De-escalation Studies
About
We are pleased to invite you to the first symposium hosted by the EU funded Joint Action EUnetCCC in collaboration with the European Academy of Cancer Sciences: Innovating Cancer Care Through De-escalation Studies. Professionals from across disciplines will gather in Amsterdam to identify key challenges and develop solutions on the topic of high-quality de-escalation studies aimed at safely reducing the intensity of cancer treatments while maintaining optimal outcomes for patients.
The event will bring together up to 200 participants including clinicians, researchers, policy makers, bioinformaticians, healthcare professionals, patient representatives and key industry stakeholders relevant for de-escalation studies.
The symposium is organized by the Task for Cancer Research in joint action EUnetCCC.
Date: 5-6 March, 2026
Venue: Netherlands Cancer Institute (NKI), Amsterdam, Netherlands
Format: On-site
- Registration Fee: Free of charge
- Travel & Accommodation: Participants are responsible for their own travel and accommodation expenses. For more info, go here:
Registration Opens On: 1 December 2025
Registration Closes On: 1 February 2026
Target Audience: Researchers, health care professionals, patient representatives, industry and policy makers
Key highlights:
- The current paradigms in cancer de-escalation trials
- How to tell patients that less can be more in cancer care?
- Biomarkers enabling treatment reduction
- Immunotherapy – can we stop early?
- How to realize de-escalation trials?